In 2016, a study published in the journal Nature identified CD32 as a surface marker for HIV-infected CD4+ T cells that are in a state of latency. The researchers found that CD32 was expressed on a subset of CD4+ T cells that were infected with HIV but not actively producing the virus. This discovery has significant implications for the development of strategies to target and eliminate latently infected cells, which is a major challenge in HIV cure research.
Research on CD32 has gained attention in the context of HIV (Human Immunodeficiency Virus) infection. Studies have shown that CD32 is expressed on the surface of certain immune cells, including macrophages and natural killer cells, which are targets for HIV infection. cd32 hiv
One specific area of interest is the role of CD32 in HIV latency. HIV latency is characterized by a state of viral dormancy, where the virus remains transcriptionally inactive despite being integrated into the host genome. CD32 has been identified as a marker for latently infected CD4+ T cells, which are a major reservoir for HIV. In 2016, a study published in the journal